BIO vs BOW · rev $2.58B vs P/E 16, rev $425.7M
BIO (BIO) versus Bowhead Specialty Holdings Inc. (BOW) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported BOW revenue for 2024-12-31 was $425.7M. Net income was $38.2M. Revenue was up 50.2% from 2023-12-31 to 2024-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
BIO currently screens at market cap $0. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Not investment advice. Open the BIO and BOW stock pages for the full models.
Not investment advice.